AAAAAA

   
Results: 1-20 |
Results: 20
Induction of indoleamine 2,3-dioxygenase in vivo by IFN-Con1
Authors: Sweeten, TL Ferris, M McDougle, CJ Kwo, P Taylor, MW
Citation: Tl. Sweeten et al., Induction of indoleamine 2,3-dioxygenase in vivo by IFN-Con1, J INTERF CY, 21(8), 2001, pp. 631-633
A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders
Authors: Posey, DJ Guenin, KD Kohn, AE Swiezy, NB McDougle, CJ
Citation: Dj. Posey et al., A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders, J CH AD PSY, 11(3), 2001, pp. 267-277
Reply to comments on "Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: An open-label pilot study"
Authors: Potenza, MN McDougle, CJ
Citation: Mn. Potenza et Cj. Mcdougle, Reply to comments on "Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: An open-label pilot study", J CL PSYCH, 21(2), 2001, pp. 246-247
The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders
Authors: Posey, DJ McDougle, CJ
Citation: Dj. Posey et Cj. Mcdougle, The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders, HARV R PSYC, 8(2), 2000, pp. 45-63
Research Units on Pediatric Psychopharmacology (RUPP) autism network - Background and rationale for an initial controlled study of risperidone
Authors: McDougle, CJ Scahill, L McCracken, JT Aman, MG Tierney, E Arnold, LE Freeman, BJ Martin, A McGough, JJ Cronin, P Posey, DJ Riddle, MA Ritz, L Swiezy, NB Vitiello, B Volkmar, FR Votolato, NA Walson, P
Citation: Cj. Mcdougle et al., Research Units on Pediatric Psychopharmacology (RUPP) autism network - Background and rationale for an initial controlled study of risperidone, CH ADOLESC, 9(1), 2000, pp. 201
Repetitive thoughts and behavior in pervasive developmental disorders: Treatment with serotonin reuptake inhibitors
Authors: McDougle, CJ Kresch, LE Posey, DJ
Citation: Cj. Mcdougle et al., Repetitive thoughts and behavior in pervasive developmental disorders: Treatment with serotonin reuptake inhibitors, J AUTISM D, 30(5), 2000, pp. 427-435
Assessment in multisite randomized clinical trials of patients with autistic disorder: The autism RUPP network
Authors: Arnold, LE Aman, MG Martin, A Collier-Crespin, A Vitiello, B Tierney, E Asarnow, R Bell-Bradshaw, F Freeman, PJ Gates-Ulanet, P Klin, A McCracken, JT McDougle, CJ McGough, JJ Posey, DJ Scahill, L Swiezy, NB Ritz, L Volkmar, F
Citation: Le. Arnold et al., Assessment in multisite randomized clinical trials of patients with autistic disorder: The autism RUPP network, J AUTISM D, 30(2), 2000, pp. 99-111
Secretin in autism - A parent's perspective
Authors: Klaeger, D Haute, T McDougle, CJ
Citation: D. Klaeger et al., Secretin in autism - A parent's perspective, J AUTISM D, 30(1), 2000, pp. 72-73
A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder
Authors: McDougle, CJ Epperson, CN Pelton, GH Wasylink, S Price, LH
Citation: Cj. Mcdougle et al., A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder, ARCH G PSYC, 57(8), 2000, pp. 794-801
Tic-related versus non-tic-related obsessive-compulsive disorder
Authors: Leckman, JF McDougle, CJ Pauls, DL Peterson, BS Grice, DE King, RA Scahill, L Price, LH Rasmussen, SA
Citation: Jf. Leckman et al., Tic-related versus non-tic-related obsessive-compulsive disorder, LEA SER PER, 2000, pp. 43-68
The role of neuroleptics in treatment-refractory obsessive-compulsive disorder
Authors: McDougle, CJ Epperson, CN Price, LM
Citation: Cj. Mcdougle et al., The role of neuroleptics in treatment-refractory obsessive-compulsive disorder, LEA SER PER, 2000, pp. 371-391
Risperidone in the treatment of two very young children with autism
Authors: Posey, DJ Walsh, KH Wilson, GA McDougle, CJ
Citation: Dj. Posey et al., Risperidone in the treatment of two very young children with autism, J CH AD PSY, 9(4), 1999, pp. 273-276
Risperidone addition in serotonin reuptake inhibitor-resistant trichotillomania: Three cases
Authors: Epperson, CN Fasula, D Wasylink, S Price, LH McDougle, CJ
Citation: Cn. Epperson et al., Risperidone addition in serotonin reuptake inhibitor-resistant trichotillomania: Three cases, J CH AD PSY, 9(1), 1999, pp. 43-49
Paroxetine in autism
Authors: Posey, DJ Litwiller, M Koburn, A McDougle, CJ
Citation: Dj. Posey et al., Paroxetine in autism, J AM A CHIL, 38(2), 1999, pp. 111-112
Possible role of neuropeptides in obsessive compulsive disorder
Authors: McDougle, CJ Barr, LC Goodman, WK Price, LH
Citation: Cj. Mcdougle et al., Possible role of neuropeptides in obsessive compulsive disorder, PSYCHONEURO, 24(1), 1999, pp. 1-24
Limited efficacy of ketoconazole in treatment-refractory major depression
Authors: Malison, RT Anand, A Pelton, GH Kirwin, P Carpenter, L McDougle, CJ Heninger, GR Price, LH
Citation: Rt. Malison et al., Limited efficacy of ketoconazole in treatment-refractory major depression, J CL PSYCH, 19(5), 1999, pp. 466-470
Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: An open-label pilot study
Authors: Potenza, MN Holmes, JP Kanes, SJ McDougle, CJ
Citation: Mn. Potenza et al., Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: An open-label pilot study, J CL PSYCH, 19(1), 1999, pp. 37-44
Brief report: Two-year control of behavioral symptoms with risperidone in two profoundly retarded adults with autism
Authors: Dartnall, NA Holmes, JP Morgan, SN McDougle, CJ
Citation: Na. Dartnall et al., Brief report: Two-year control of behavioral symptoms with risperidone in two profoundly retarded adults with autism, J AUTISM D, 29(1), 1999, pp. 87-91
Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: An open-label case series
Authors: Weiss, EL Potenza, MN McDougle, CJ Epperson, CN
Citation: El. Weiss et al., Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: An open-label case series, J CLIN PSY, 60(8), 1999, pp. 524-527
Effects of catecholamine depletion with AMPT (alpha-methyl-para-tyrosine) in obsessive-compulsive disorder
Authors: Longhurst, JG Carpenter, LL Epperson, CN Price, LH McDougle, CJ
Citation: Jg. Longhurst et al., Effects of catecholamine depletion with AMPT (alpha-methyl-para-tyrosine) in obsessive-compulsive disorder, BIOL PSYCHI, 46(4), 1999, pp. 573-576
Risultati: 1-20 |